PharmaMar shared on X:
“We’re already at ESMO 2026!
Madrid welcomes the international oncology community, and we are taking part with an agenda focused on research, knowledge-sharing and international collaboration.
Throughout the congress, our participation includes:
- Two research posters exploring oncology research and the use of artificial intelligence in research processes.
- Two posters from the CLARISSE study, presented by ICAPEM with PharmaMar’s collaboration, examining sex-based differences in small cell lung cancer and participation in clinical trials.
- An Industry Satellite Symposium bringing together international experts to discuss the current landscape of extensive-stage SCLC.
Read more: More Time for Patients: Reframing the Course of ES-SCLC
Find us at booth 1066 | IFEMA Madrid
You can also read: 20 Posts Not to Miss from ESMO Congress 2026: Day 1
